GALWAY, IRELAND--August 13, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--French pharma company Sanofi (NASDAQ:SNY) (Paris, France) has confirmed plans to invest 1.3 billion euro (US$1.5 billion) to build a new insulin plant at its Frankfurt Höchst campus in Germany. Within this article: Details Sanofi's German investment to boost insulin supply, project details and timeline, existing operations, recent French investment, Germany's new Pharmaceutical Strategy and recent investment by pharma majors
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
